Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 39 (RPL21P39) is a processed pseudogene related to the gene encoding human ribosomal protein L21. Pseudogenes such as RPL21P39 are stretches of DNA that resemble known genes but typically do not encode functional proteins; they arise from duplication or retrotransposition events and often accumulate mutations. There is no established biological function, disease association, or therapeutic relevance for this pseudogene. The functional ribosomal protein L21 (encoded by RPL21), in contrast, is a structural constituent of the ribosome required for protein synthesis[3][5][7]. Mutations in the RPL21 gene—not its pseudogenes—cause disorders like Hypotrichosis simplex. Summary Notes: - RPL21P39 is not a protein-coding gene and should not be confused for an active biomolecular target. - If a therapeutic, biomarker, or molecular target was intended, RPL21 (not RPL21P39) is correct; otherwise, for pseudogenes (like RPL21P39), these fields are null[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 39 (RPL21P39).